For biopharmaceutical organizations who need the power and performance of LC-MS for routine screening and multi-attribute monitoring (MAM), with the BioAccord™ Waters has designed the first SmartMS™-enabled biopharma LC-MS solution.
We’re used to turning on a device and using it immediately. However, previous LC-MS systems require extensive setup before analysis can begin – 30, 40, 50, or more clicks to specify analytical parameters, usually with open fields and values to enter. The BioAccord sets itself up so that a user can begin an analysis in as few as two clicks; one to specify the mass range, the other to start the analysis.
Along with having a simple interface and automated operation, we expect smart devices to work together seamlessly. In LC-MS biopharma analysis, this means that chromatography, mass spectrometry, software, chemistries, and service all perform as one. The BioAccord integrates all elements in order to produce the most reliable and reproducible, compliance-ready data giving scientists confidence and insights to make decisions when developing biotherapeutics.